Emile Naccasha

University of Chicago — United States

Medicine · Health Sciences

3h-index68citations18works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Brain Metastases and Treatment(11), Radiopharmaceutical Chemistry and Applications(10), Cancer Immunotherapy and Biomarkers(3), Immunotherapy and Immune Responses(2), Chemokine receptors and signaling(2)

Publications18 total

Publisher Correction: Radiation-induced amphiregulin drives tumour metastasis
Nature·2025Open Access
Radiotherapy induces YTHDF2 in dendritic cells impairing cross-presentation and T cell function
The Journal of Experimental Medicine·2025Open Access
Targeting gut microbiota and arginase boosts MEK inhibitors’ enhancement of antitumour immunity via MHC-I upregulation in colorectal cancer
British Journal of Cancer·2025· 2 citedOpen Access
YTHDFs as radiotherapy checkpoints in tumor immunity
The Journal of Experimental Medicine·2025· 1 cited
Radiation-induced amphiregulin drives tumour metastasis
Nature·2025· 41 cited
Supplementary Figure S3 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S2 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S7 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S5 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Data from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S10 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S4 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S8 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S6 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S9 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
Supplementary Figure S1 from Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
2024Open Access
YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN production
Journal of Clinical Investigation·2024· 18 citedOpen Access
Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance
Clinical Cancer Research·2024· 6 citedOpen Access

Frequent Co-authors

Hua Liang(17), Ralph R. Weichselbaum(17), András Piffkó(16), Liangliang Wang(16), Jason Bugno(16), Chuan He(16), Kaiting Yang(15), Xianbin Yu(14), Jiaai Wang(14), Xiaona Huang(14), Stephen Y. Luo(13), Xuezhi Cao(12), Katherine Chen(12), Yuzhu Hou(12), Sherry Fu(12), Yang‐Xin Fu(12), Chuangyu Wen(6), Steven J. Chmura(4), Sean P. Pitroda(4), Katarzyna Zawieracz(3)